Autoimmune bullous skin disease
MONDO:0019337An autoimmune disease characterized by blisters on the skin.
Also known as: bullous skin disease, bullous dermatosis
91 clinical trials for this condition and its sub-types, 7 tagged with Autoimmune bullous skin disease itself.
Follow this condition to get notified about new trialsWhere it sits in the disease tree
Browse by category →Sub-types of Autoimmune bullous skin disease
-
Pemphigus 20 trials · 27 incl. sub-types
6 sub-types
- Pemphigus vulgaris 13 trials Sub-types →
- Pemphigus foliaceus 3 trials · 6 incl. sub-types Sub-types →
- Hailey-Hailey disease 3 trials
- Herpetiform pemphigus 0 trials
- Pemphigoid gestationis 0 trials
- Pemphigus erythematosus 0 trials
-
Bullous pemphigoid 18 trials
-
Mucous membrane pemphigoid 5 trials · 9 incl. sub-types
1 sub-type
- Ocular cicatricial pemphigoid 4 trials
-
Acquired epidermolysis bullosa 3 trials
-
Dermatitis herpetiformis 1 trial
2 sub-types
- Dermatitis herpetiformis, familial 0 trials
- Juvenile dermatitis herpetiformis 0 trials
-
Pemphigoid 1 trial
-
IgA pemphigus 0 trials
-
Anti-p200 pemphigoid 0 trials
-
Linear IgA Dermatosis 0 trials
-
Paraneoplastic pemphigus 0 trials
-
Subcorneal pustular dermatosis 0 trials
Most studied deeper sub-types
-
Engineered immune cells take aim at Hard-to-Treat autoimmune diseases
Disease control Recruiting nowThis early-stage trial tests an experimental cell therapy called NEUK203-215 in adults aged 18-65 with severe autoimmune diseases like lupus or scleroderma that have not responded to other treatments. The therapy uses immune cells from a healthy donor, engineered to target and at…
Early phase 1 • Sponsor: Neukio Biotherapeutics (Shanghai) Co., Ltd. • Aim: Disease control
Last updated Jul 17, 2026 00:00 UTC
-
New antibody treatment offers hope for rare blistering skin disease
Disease control Recruiting nowThis study tests a new drug called CM336 in 30 adults with moderate to severe autoimmune bullous disease, a condition where the immune system attacks the skin causing painful blisters. The drug targets specific immune cells to reduce this attack. The main goal is to see if the dr…
Phase 2 • Sponsor: Shandong First Medical University • Aim: Disease control
Last updated Jun 27, 2026 12:04 UTC
-
Can a skin biopsy tell your doctor which treatment will work?
Knowledge-focused Recruiting nowThis study is collecting skin and blood samples from 830 people with chronic inflammatory skin diseases like psoriasis, eczema, and lupus. Researchers want to find biological markers that can predict how well a person will respond to treatment after one year. The goal is to move …
Sponsor: Assistance Publique - Hôpitaux de Paris • Aim: Knowledge-focused
Last updated Jun 27, 2026 13:08 UTC
-
Scientists probe hidden clot risks in autoimmune skin disorders
Knowledge-focused Recruiting nowThis study looks at blood clotting in people with autoimmune skin diseases like bullous pemphigoid and lupus. Researchers will collect blood samples from 39 participants—some with active disease and some with mild or controlled disease—plus 15 healthy controls. They will measure …
Sponsor: University of Nebraska • Aim: Knowledge-focused
Last updated Jun 27, 2026 12:31 UTC
-
Scientists launch hunt for clues in autoimmune skin diseases
Knowledge-focused Recruiting nowThis study aims to create a large collection of blood samples and medical information from 800 people with autoimmune or inflammatory skin diseases. Researchers will use these samples to find new biomarkers and better understand what causes these conditions. The goal is to help d…
Sponsor: University Hospital, Toulouse • Aim: Knowledge-focused
Last updated Jun 27, 2026 11:03 UTC